✦ LIBER ✦

Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat

✍ Scribed by Sinéad Walsh; Katarzyna Mnich; Ken Mackie; Adrienne M. Gorman; David P. Finn; Eilís Dowd

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Striatal Cannabinoid CB1 Receptor mRNA E

✍ M.A. Silverdale; S. McGuire; A. McInnes; A.R. Crossman; J.M. Brotchie 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Acupuncture prevents 6-hydroxydopamine-i

✍ H.i-Joon Park; Sabina Lim; Wan-Seok Joo; Chang-Shik Yin; Hyang-Sook Lee; Hye-Jun 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 224 KB

The antioxidant drink “effective microor

✍ K. P. Datla; R. D. Bennett; V. Zbarsky; O. I. Aruoma; D. T. Dexter; B. Ke; Y.-F. 📂 Article 📅 2004 🏛 Pharmaceutical Press 🌐 English ⚖ 414 KB

Effect of Different Doses of Estrogen on

✍ Marcela Ferreira Cordellini; Giovana Piazzetta; Karin Cristine Pinto; Ana Márcia 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 262 KB

Effects of rimonabant, a selective canna

✍ Sara González; Camila Scorticati; Moisés García-Arencibia; Rosario de Miguel; Jo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Modeling Parkinson's Disease in Rats: An

✍ Ronald Deumens; Arjan Blokland; Jos Prickaerts 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 275 KB